181 related articles for article (PubMed ID: 21252713)
1. Nodal staging in lung cancer: lymph node location or number?
Rusch VW; Giroux DJ
J Thorac Oncol; 2011 Feb; 6(2):237-8. PubMed ID: 21252713
[No Abstract] [Full Text] [Related]
2. eComment: Stage IIIA-N2 non-small cell lung cancer: could a new scoring system improve the management of heterogeneous disease?
Lococo F; Leuzzi G; Cafarotti S; Margaritora S
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):738. PubMed ID: 21555438
[No Abstract] [Full Text] [Related]
3. Is sampling really effective in staging non-small cell lung cancer? A prospective study.
Magnanelli G; Scanagatta P; Benato C; Terzi A; Lonardoni A; Falezza G; Furlan G; Calabrò F
Chir Ital; 2006; 58(1):19-22. PubMed ID: 16729605
[TBL] [Abstract][Full Text] [Related]
4. Validation of pN2 sub-classifications in patients with pathological stage IIIA N2 non-small cell lung cancer.
Nakagiri T; Sawabata N; Funaki S; Inoue M; Kadota Y; Shintani Y; Okumura M
Interact Cardiovasc Thorac Surg; 2011 May; 12(5):733-8. PubMed ID: 21297135
[TBL] [Abstract][Full Text] [Related]
5. Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.
De Leyn P; Dooms C; Kuzdzal J; Lardinois D; Passlick B; Rami-Porta R; Turna A; Van Schil P; Venuta F; Waller D; Weder W; Zielinski M
Eur J Cardiothorac Surg; 2014 May; 45(5):787-98. PubMed ID: 24578407
[TBL] [Abstract][Full Text] [Related]
6. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
[TBL] [Abstract][Full Text] [Related]
7. Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification?
Wei S; Asamura H; Kawachi R; Sakurai H; Watanabe S
J Thorac Oncol; 2011 Feb; 6(2):310-8. PubMed ID: 21206387
[TBL] [Abstract][Full Text] [Related]
8. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
9. Can a thoracic surgeon identify lymph node metastases during surgery based on their size? Analysis of 844 metastatic and 10,462 nonmetastatic lymph nodes.
Suemitsu R; Takeo S; Matsuzawa H; Yamaguchi M; Momosaki S; Uesugi N
J Thorac Oncol; 2010 Mar; 5(3):349-53. PubMed ID: 20009772
[TBL] [Abstract][Full Text] [Related]
10. Mode of spread in the early phase of lymphatic metastasis in non-small-cell lung cancer: significance of nodal micrometastasis.
Izbicki JR; Passlick B; Hosch SB; Kubuschock B; Schneider C; Busch C; Knoefel WT; Thetter O; Pantel K
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):623-30. PubMed ID: 8800148
[TBL] [Abstract][Full Text] [Related]
11. Node Doubt: Rigorous Surgical Nodal Procurement Combined With Thorough Pathologic Evaluation Improves Non-Small Cell Lung Carcinoma Staging Accuracy.
Butnor KJ; Asamura H; Travis WD
Ann Thorac Surg; 2016 Aug; 102(2):353-6. PubMed ID: 27449422
[No Abstract] [Full Text] [Related]
12. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
13. Routine mediastinoscopy and lymph node staging: 'much ado about nothing'?
Dujon A; Le Pimpec Barthes F; Saab M; Riquet M
Eur J Cardiothorac Surg; 2002 Sep; 22(3):485; author reply 486. PubMed ID: 12204755
[No Abstract] [Full Text] [Related]
14. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China.
Li Z; Yu Y; Lu J; Luo Q; Wu C; Liao M; Zheng Y; Ai X; Gu L; Lu S
J Thorac Oncol; 2009 Jun; 4(6):702-9. PubMed ID: 19404215
[TBL] [Abstract][Full Text] [Related]
15. Analysis of risk factors for skip lymphatic metastasis and their prognostic value in operated N2 non-small-cell lung carcinoma.
Benoit L; Anusca A; Ortega-Deballon P; Cheynel N; Bernard A; Favre JP
Eur J Surg Oncol; 2006 Jun; 32(5):583-7. PubMed ID: 16621424
[TBL] [Abstract][Full Text] [Related]
16. ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer.
Lardinois D; De Leyn P; Van Schil P; Porta RR; Waller D; Passlick B; Zielinski M; Lerut T; Weder W
Eur J Cardiothorac Surg; 2006 Nov; 30(5):787-92. PubMed ID: 16971134
[TBL] [Abstract][Full Text] [Related]
17. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
18. A pragmatic approach to the diagnosis of nodal micrometastases in early stage non-small cell lung cancer.
Herpel E; Muley T; Schneider T; Palm E; Kieslich de Hol D; Warth A; Meister M; Storz K; Schnabel PA; Schirmacher P; Dienemann H; Hoffmann H
J Thorac Oncol; 2010 Aug; 5(8):1206-12. PubMed ID: 20581709
[TBL] [Abstract][Full Text] [Related]
19. [Detection of occult tumor cells in resected lymph nodes of patients with stage I carcinoma and its clinico-pathological significance].
Chen Z; Lu X; Huang R
Zhonghua Zhong Liu Za Zhi; 1997 Jan; 19(1):69-71. PubMed ID: 10743062
[TBL] [Abstract][Full Text] [Related]
20. Surgical treatment of non-small cell lung cancer: mediastinal lymph node dissection.
Meacci E; Margaritora S; Cesario A; Porziella V; Kawamukai K; Piraino A; Vita ML; Tessitore A; Cusumano G; Granone P
Rays; 2004; 29(4):423-9. PubMed ID: 15852730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
